# Synapsica Healthcare Pvt

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/synapsica-healthcare-pvt

- Industry: Software
- Headquarters: New Delhi, India
- Website: www.synapsica.com
- Total disclosed funding: $4.3M
- Latest round: Series A (Jun 23, 2021)
- Investors on record: 5

## About

Synapsica Healthcare Pvt Ltd specializes in AI-driven radiology software solutions that enhance spine imaging reporting and improve diagnostic accuracy for healthcare providers and radiologists.Founded in 2017 in New Delhi, India, Synapsica Healthcare Pvt Ltd develops innovative AI software designed for radiology. The company has successfully raised INR 311.9 million in its Series A funding round on June 23, 2021, co-led by Endiya, IvyCap Ventures, and Y Combinator, totaling INR 311.9 million raised to date. The company operates without any known parent or subsidiary entities, and its leadership includes CEO Meenakshi Singh, who is among the founding team alongside Cherian Dr, Gandharv Goyal, Kuldeep Chauhan, and Meenakshi Singh.Synapsica offers AI-driven radiology software solutions specifically designed to enhance spine imaging reporting, which includes products like Spindle, SpindleX, and Crescent. These AI reporting assistants automate the generation of preliminary reports by performing necessary spinal measurements and characterizing degenerative disc diseases, as well as analyzing stress x-rays of the spine. The Spindle product focuses on MRI spine analysis, delivering detailed mensuration of spinal elements while identifying variations and pathologies. SpindleX automates reporting for stress x-rays by quantifying abnormalities related to injuries or degeneration. Crescent, while aimed at chest X-rays, provides similar functionalities in identifying and characterizing lesions. Synapsica’s client base consists of healthcare providers, radiologists, and medical facilities primarily in the United States and India, addressing the growing demand for efficient, accurate imaging solutions across these geographical markets.In 2021, Synapsica reported revenue of INR 279,078.9 and an EBITDA of INR -196,987.6. The company generates revenue through subscription-based models for its suite of AI solutions tailored for radiology. Clients such as hospitals and diagnostic centers engage with the company by subscribing to various products like Spindle and SpindleX for a predetermined period, ensuring continuous updates and support through a structure of recurring fees.As part of its future growth strategy, Synapsica plans to leverage the INR 311.9 million raised in its Series A funding to support international expansion and enhance its suite of AI features. The company aims to introduce new products designed for advanced radiology applications, expanding its offerings beyond the current solutions. Additionally, Synapsica is targeting new geographic markets for growth, specifically aiming to broaden its presence in North America and potentially Europe by 2023.

## Funding rounds

- Series A, Jun 23, 2021, $4.2M — Y Combinator, IvyCap Ventures Group, Endiya
- Seed, Dec 14, 2020 — [DUP] International Finance Corporation, Stellaris Venture Partners
- Seed, Mar 17, 2020, $0.1M — Y Combinator

## Investors

- Y Combinator (https://capitalatlas.ai/funds/y-combinator) — Seed, Series A
- [DUP] International Finance Corporation — Seed
- Stellaris Venture Partners (https://capitalatlas.ai/funds/stellaris-venture-partners) — Seed
- IvyCap Ventures Group (https://capitalatlas.ai/funds/ivycap-ventures-group) — Series A
- Endiya (https://capitalatlas.ai/funds/endiya) — Series A